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We do not need to rehearse the grim story of the glob-
al rise of antibiotic resistant microbes. But what if it 
were possible to control the rate with which antibiotic 
resistance evolves by de novo mutation? It seems that 
some bacteria may already do exactly that: they modi-
fy the rate at which they mutate to antibiotic re-
sistance dependent on their biological environment. In 
our recent study [Krašovec, et al. Nat. Commun. (2014), 
5, 3742] we find that this modification depends on the 
density of the bacterial population and cell-cell inter-
actions (rather than, for instance, the level of stress). 
Specifically, the wild-type strains of Escherichia coli we 
used will, in minimal glucose media, modify their rate 
of mutation to rifampicin resistance according to the 
density of wild-type cells. Intriguingly, the higher the 
density, the lower the mutation rate (Figure 1). Why 
this novel density-dependent ‘mutation rate plasticity’ 
(DD-MRP) occurs is a question at several levels. An-
swers are currently fragmentary, but involve the quor-
um-sensing gene luxS and its role in the activated me-
thyl cycle. 
 
The first level of questions about DD-MRP concern how the 
density dependence occurs. This ‘upstream’ mechanism 
requires the well-known quorum-sensing gene luxS. When 
luxS is deleted, the density dependence of their mutation 
rate goes away. And when wild-type cells are co-cultured 
with ΔluxS cells, their mutation rate goes up as though the 
ΔluxS cells were not contributing to the perceived cell den-
sity. This immediately suggests a role for the quorum-
sensing signal, autoinducer 2 (AI-2), uniquely produced by 
the LuxS protein. However, the story is not that simple – 
adding AI-2 does not decrease the wild-type mutation rate 
as would be predicted if it were the mediator. Rather, it 
seems that the metabolic role of the LuxS protein in the 
activated methyl cycle is required. Indirectly replenishing 
this cycle by adding the amino acid aspartate to the medi-
um functionally complements the luxS deletion, bringing 
back the DD-MRP. This still leaves open the question of 
what the upstream signal, by which density is perceived, 
actually is. In principle it could be anything acting non-cell-
autonomously downstream of luxS via the activated methyl 
cycle. A prime candidate might be the elusive molecule 
autoinducer 3, an important regulator of virulence gene 
expression in enteropathogenic E. coli. However, while the 
precise identity of that molecule remains unknown, its 
relevance to DD-MRP is likely to remain speculative. 
The second level of questions is what kind of ‘down-
stream’ mechanism is involved. The number of mutations 
in any organism results from a balance between mutation 
generation and DNA repair. The mechanism of this DD-
MRP could therefore, in principle, involve modifying muta-
genesis, DNA repair or both. The initial evidence (transcrip-
tional analyses) does not support a role for error-prone 
DNA-polymerases IV and V, both known to be involved in 
the only other well characterised example of MRP, stress-
induced mutagenesis. Among DNA repair mechanisms, 
indirect evidence from our analysis of published transcrip-
tional data suggests a possible role for the mutS gene. Per-
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haps most intriguing, and also consistent with the indirect 
evidence, is the possibility that DNA methylation is in-
volved in DD-MRP. This idea comes from the fact that 
methylation sites used by the Dam and Dcm methylases 
are known to be mutational hotspots. Furthermore, two 
key sites known to confer rifampicin resistance in E. coli, 
and hence major contributors to our mutation rate esti-
mates, are such methylation sites (the adenine residues in 
the common palindrome GATC). These facts may be rele-
vant to our observation that DD-MRP depends on luxS’s 
role in the cycle supplying methyl groups to DNA methyl-
ases. One can therefore hypothesise that differential 
methylation could be causally involved in DD-MRP. 
The third and final ‘why’ is less mechanistic: why has 
DD-MRP evolved and been maintained in wild-type bacte-
ria? The default answer has to be that DD-MRP is a by-
product of something else that more directly affects the 
fitness of the cell. Perhaps it is a side-effect of quorum-
sensing activation (whose evolutionary role is much debat-
ed in its own right). If this connection is not especially cost-
ly, and/or is genetically difficult to remove without a cost, 
DD-MRP could be ‘just’ an interesting quirk. This is not a 
particularly satisfying hypothesis: one might expect any-
thing other than minimised mutation rates to impose a 
cost in terms of mutant offspring and so be selected 
against unless they are somehow beneficial. Also, removal 
of luxS straightforwardly removed DD-MRP without a cost 
we could measure in the laboratory. There are however 
other possibilities. We were looking for plastic mutation 
rates precisely because we and others are developing 
mathematical theory, demonstrating that MRP can be 
beneficial. In particular, it can be beneficial if mutation 
rates are minimized when an organism is as fit as it can be 
(i.e. at an adaptive peak), and increased when the organ-
ism is doing badly. This makes intuitive sense: when a gen-
otype is displaced from an adaptive peak, the deleterious 
effects of a raised mutation rate could be outweighed by 
the potential for increased fitness via mutation. We have 
found this to occur in mathematical models of adaptive 
landscapes and in in silico evolution of DNA sequences 
binding particular transcription factors. Whether such ben-
eficial MRP exists in biology, however, remains to be seen. 
DD-MRP requiring luxS does indeed give a mutation rate 
that is often lowest when the individuals have high fitness 
and increases at lower fitness. Nonetheless, the evidence is 
not yet there to say that this process actually does benefit 
the organisms, let alone that it evolved and/or is main-
tained because of this benefit. These are issues that need 
to be resolved experimentally, both over the time-scales of 
experimental evolution and the longer stretches of evolu-
 
 
FIGURE 1: Density-dependent mutation rate plasticity in E. coli. The green contours indicate mutation rates for E. coli with a functional Acti-
vated Methyl Cycle (AMC; green cell) across a range of population densities. In the example cells in the plot corners, a blue and red explosion 
indicates a mutational event resulting in a rifampicin resistant cell. The orange contours correspond to luxS deletant cells which don’t pro-
duce the signal (arrows coming from the green cell) and have an incomplete AMC (orange cell). Contours are density plots across all the data 
from Krašovec et al. 2014 (344 data points, 77 of which correspond to the orange contours), including both E. coli B and K12 strains and ac-
counting for all the effects noted there (e.g., data from the complemented ΔluxS mutant are included in the green area, not the orange). 
Abbreviations: HCY, homocysteine; MET, methionine; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine; SRH, S-
ribosylhomocysteine.  
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tion among different prokaryotic, and indeed eukaryotic, 
microbes.  
All the scientific issues above seem tractable. However, 
they prompt broader questions: ‘Why is DD-MRP interest-
ing?’ and ‘Why has no-one discovered it before?’. The fluc-
tuation test, on which our findings are based, was first 
used in the 1940s and rifampicin was produced in 1959. 
Since then, fluctuation tests using rifampicin have become 
commonplace for estimating mutation rates. Perhaps the 
previous non-discovery of DD-MRP comes down to statis-
tics – fluctuation tests are noisy and laborious assays. Only 
differences in mutation rate between wild-type and muta-
tor strains, which typically have at least an order of magni-
tude higher mutation rate (e.g., due to deficiency in DNA 
repair), can be reliably separated within a single experi-
ment. We, by contrast, are observing variation in mutation 
rates of around 3 to 5-fold (see Figure 1). It seems entirely 
plausible that, to a bacterium, even a small increase in the 
chance of gaining an antibiotic resistance mutation is, bio-
logically, highly significant. However, to detect this differ-
ence using fluctuation tests required large numbers of as-
says and some careful statistical models. Even then we 
were only really convinced of DD-MRP when it became 
clear that we could remove it by deleting luxS and reinstate 
it by functionally complementing that mutation. Which 
brings us to the question of DD-MRP’s significance – why 
should one care about a phenomenon close to the limits of 
detectability, and subtle, relative to the large fixed differ-
ences in mutation rate between wild-type and mutator 
strains?  
Firstly, we believe DD-MRP is interesting because it 
connects previously disparate areas of microbiology: mu-
tagenesis and quorum-sensing. A vast amount of 
knowledge has been built up in both areas and DD-MRP 
opens a bridge between the two. It’s interesting too as an 
evolutionary mechanism, particularly where that relates to 
mathematical models and theory. The independence of 
mutational effects from the environment in which they 
arise has been a hard-won insight. Nonetheless, evolution 
depends ultimately upon mutations and intimately upon 
the environment. Links between the two therefore have 
the potential to affect the realized trajectory of evolution. 
Finally, there is the interest of what DD-MRP might mean 
practically. If mutation rates in general, and those to anti-
biotic resistance in particular, can be manipulated via a 
quorum-sensing-like mechanism, it opens up fascinating 
possibilities for how microbes might be manipulating each 
other and ultimately, how humans might manipulate them 
too. In particular, there are many circumstances outside 
the laboratory when E. coli cells find themselves at low 
densities, for instance, when treated by antibiotics in the 
human gut or when first infecting a host. If it were possible 
to develop a molecule that prevents E. coli cells from rec-
ognizing their scarcity, our results suggest that this could 
reduce the rate at which antibiotic resistance arises. If ad-
ministered with existing antibiotics, such a molecule might 
increase or prolong their efficacy. Such a mutation rate 
minimization approach could perhaps result in new tools to 
tackle the rise in antibiotic resistance. After all, attine ants 
have apparently succeeded in suppressing microbial path-
ogens using bacterial antibiotics for millennia without ob-
viously ‘inventing’ new classes of antibiotic. Perhaps the 
identification of density-dependent mutation rates will 
play a part in humans learning the same trick. 
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